The world's largest manufacturer of plant-extract medicines, Germany-based Willmar Schwabe Group, is considering setting up a research and development (R&D) center in Taiwan to look into traditional herbal remedies, officials from the company and the government said yesterday.
"We are interested in doing research in Taiwan, as traditional plant medicine is strong here," said Heinz Stumpf, head of Schwabe's R&D department.
"The knowledge and tradition is here, and there are scientists who can cooperate with us," he said.
Founded in 1866 in Leipzig, Schwabe now employs 3,000 people worldwide and reported revenues of 420 million euros last year, 15.3 million of which was channeled into R&D. The company is best known for its gingko-biloba products.
As the standard of scientific research in Taiwan is high, Stumpf praised the nation as the company's first choice.
Indeed, Schwabe's Taiwanese partners urged the government to do its utmost to fight off competition from neighboring countries.
"Many countries in the region, such as Singapore and Korea, are asking Schwabe to set up an R&D center in their countries," said Su Zhi-hong (
Stumpf and Schwabe's president Klaus-Peter Schwabe arrived in Taipei on Tuesday at the invitation of the government which is keen to attract more research centers to the country in key industries.
"We are very happy to be welcoming the world's largest plant medicine group to Taiwan," said Song Liu (
The ministry's five-year science and technology program for Chinese herbal medicine has US$5 billion to spend on establishing the nation as a center of excellence for biotechnology, Liu added.
The government has plenty of sweeteners to lure Schwabe.
"Taiwan has attractive incentives for companies like Schwabe wishing to set up research centers here," Liu said.
"The most attractive aspect of locating a research center here is that costs are a third of those in Europe and the US," he said.
The new center will have a lucrative market to tap. This year, the global market for plant and herbal medicine was US$23 billion, according to research firm PhytoPhram Consulting. That figure is expected to grow to US$35 billion by 2006.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained